Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Calero

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Medicina Clinica|February 2, 2013
[Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients]Esther Quintana-Gallego, Jose Luis Lopez-Campos, Carmen Calero, et al.
Medicina Clinica|July 13, 2014
[Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis]Isabel Delgado Pecellín, Esther Quintana Gallego, Celeste Pedregal Solano, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 19, 2018
Understanding of COPD among final-year medical studentsJavier Mohigefer, Carmen Calero-Acuña, Eduardo Marquez-Martin, et al.
Plos One|October 22, 2014
Results from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studiesJose Luis Lopez-Campos, M Isabel Asensio-Cruz, Ady Castro-Acosta, et al.
Pediatric Pulmonology|November 20, 2015
Mortality from cystic fibrosis in Europe: 1994-2010Esther Quintana-Gallego, Miguel Ruiz-Ramos, Isabel Delgado-Pecellin, et al.
Biomedicines|October 23, 2021
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised MedicineLaura Carrasco-Hernández, Esther Quintana-Gallego, Carmen Calero, et al.
Respiratory Physiology & Neurobiology|November 22, 2011
Cyclooxygenase-2 -765G>C polymorphism is associated with C-reactive protein levels in resistant smokers but not in chronic obstructive pulmonary disease patientsJosé Luis López-Campos, Ana Montes-Worboys, Carmen Calero, et al.
BMC Pulmonary Medicine|June 3, 2014
Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patientsCarmen Calero, Elena Arellano, Jose Luis Lopez-Villalobos, et al.
Archivos De Bronconeumologia|June 14, 2022
Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and WorkflowLaura Carrasco Hernández, Candela Caballero Eraso, María Abad Arranz, et al.
Patient Preference and Adherence|February 6, 2015
Patient-reported outcomes and considerations in the management of COPD: focus on aclidiniumJose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Medicina Clinica|February 2, 2013
[Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients]Esther Quintana-Gallego, Jose Luis Lopez-Campos, Carmen Calero, et al.
Medicina Clinica|July 13, 2014
[Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis]Isabel Delgado Pecellín, Esther Quintana Gallego, Celeste Pedregal Solano, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 19, 2018
Understanding of COPD among final-year medical studentsJavier Mohigefer, Carmen Calero-Acuña, Eduardo Marquez-Martin, et al.
Plos One|October 22, 2014
Results from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studiesJose Luis Lopez-Campos, M Isabel Asensio-Cruz, Ady Castro-Acosta, et al.
Pediatric Pulmonology|November 20, 2015
Mortality from cystic fibrosis in Europe: 1994-2010Esther Quintana-Gallego, Miguel Ruiz-Ramos, Isabel Delgado-Pecellin, et al.
Biomedicines|October 23, 2021
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised MedicineLaura Carrasco-Hernández, Esther Quintana-Gallego, Carmen Calero, et al.
Respiratory Physiology & Neurobiology|November 22, 2011
Cyclooxygenase-2 -765G>C polymorphism is associated with C-reactive protein levels in resistant smokers but not in chronic obstructive pulmonary disease patientsJosé Luis López-Campos, Ana Montes-Worboys, Carmen Calero, et al.
BMC Pulmonary Medicine|June 3, 2014
Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patientsCarmen Calero, Elena Arellano, Jose Luis Lopez-Villalobos, et al.
Archivos De Bronconeumologia|June 14, 2022
Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and WorkflowLaura Carrasco Hernández, Candela Caballero Eraso, María Abad Arranz, et al.
Patient Preference and Adherence|February 6, 2015
Patient-reported outcomes and considerations in the management of COPD: focus on aclidiniumJose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, et al.
Pageof 5